A Star in deal with AUM Biosciences and One Biomed
In two separate dealings, AUM Biosciences has licensed its first novel, highly selective anti-cancer drug from A*STAR's Experimental Therapeutics Centre (ETC) and A*STAR's Institute of Microelectronics (IME) and One BioMed have launched a S$9 million joint lab.
Dr. Ashis Kumar Sen conferred Swarnajayanti Fellowship for his work on cancer and dengue detection
Dr. Ashis Kumar Sen is one among the three Professors to receive this Fellowship in Engineering Sciences discipline from the entire country. His main research interests are in the areas of microfluidics based interfacial phenomena and healthcare diagnostics.